Embolic Stroke: Clinical Trials

2 trials for Embolic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Embolic Stroke: new trials by email Literature Review of Embolic Stroke trials Research Report on Embolic Stroke

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lixiana Acute Stroke Evaluation Registry
Edoxaban 60 MG, Edoxaban 30 mg - Ischemic Stroke, Atrial Fibrillation
Phase 4CompletedUniversity of Alberta702018-06-012024-04-05
Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
Shuxuetong Injection, Placebo Injection - Embolic Stroke
Phase 4CompletedBeijing Tiantan Hospital24162017-05-122020-07-22

Narrower conditions

Atrial Fibrillation (1)  ·  Cerebral Hemorrhage (1)  ·  Ischemic Stroke (1)  ·  Recurrence (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Arrhythmias, Cardiac (1)  ·  Disease Attributes (1)  ·  Heart Diseases (1)  ·  Hemorrhage (1)  ·  Intracranial Hemorrhages (1)  ·  Ischemic Stroke (1)  ·  Stroke (1)

Interventions

edoxaban (1)  ·  shuxuetong (1)

Sponsors

Beijing Tiantan Hospital (1)  ·  University of Alberta (1)

Countries

Canada (1)  ·  China (1)

Top investigators

Brian Buck, MD (1)  ·  Ken Butcher, MD (1)

Results publications

PMID 32994371, PMID 33868150